Racial disparities in health insurance, triple‑negative breast cancer diagnosis, tumor stage, treatment and survival in a large nationwide SEER cohort in the United States-Reference-Cited by-同舟云学术

Racial disparities in health insurance, triple‑negative breast cancer diagnosis, tumor stage, treatment and survival in a large nationwide SEER cohort in the United States

Published:2022-03-02 Issue:4 Volume:16 Page:
ISSN:2049-9450
Container-title:Molecular and Clinical Oncology
language:
Short-container-title:Mol Clin Oncol

Author:

Du Xianglin¹

Affiliation:

1. Department of Epidemiology, Human Genetics and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX 77030 USA

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference45 articles.

1. Racial differences in survival from breast cancer: Results of the National cancer institute black/white cancer survival study;Eley;JAMA,1994

2. Racial and marital status influences on 10 year survival from breast cancer;Neale;J Clin Epidemiol,1994

3. Racial differences in survival of female breast cancer in the Detroit metropolitan area;Simon;Cancer,1996

4. Disaggregating the effects of race on breast cancer survival;Howard;Fam Med,1998

5. Race and differences in breast cancer survival in a managed care population;Yood;J Natl Cancer Inst,1999

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A self-targeting MOFs nanoplatform for treating metastatic triple-negative breast cancer through tumor microenvironment remodeling and chemotherapy potentiation;International Journal of Pharmaceutics;2024-10

2. Utilisation of endocrine therapy for cancer in Indigenous peoples: a systematic review and meta-analysis;BMC Cancer;2024-07-22

3. Assessing interventions promoting the uptake of cancer‐related genomic services within the Latino community: A scoping review using the RE‐AIM framework;Cancer Medicine;2024-07

4. Investigating phenotypic plasticity due to toxicants with exposure disparities in primary human breast cells in vitro;Frontiers in Oncology;2024-06-10

5. Racial/Ethnic Disparities in Pathologic Complete Response and Overall Survival in Patients With Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy;Journal of Clinical Oncology;2024-05-10